Items where Author is "Bocelli-Tyndall, C."

2015

Bocelli-Tyndall, C. and Trella, E. and Frachet, A. and Zajac, P. and Pfaff, D. and Geurts, J. and Heiler, S. and Barbero, A. and Mumme, M. and Resink, T. J. and Schaeren, S. and Spagnoli, G. C. and Tyndall, A.. (2015) FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Annals of the rheumatic diseases, Vol. 74, H. 1. pp. 260-266.

2014

Mele, V. and Muraro, M. G. and Calabrese, D. and Pfaff, D. and Amatruda, N. and Amicarella, F. and Kvinlaug, B. and Bocelli-Tyndall, C. and Martin, I. and Resink, T. J. and Heberer, M. and Oertli, D. and Terracciano, L. and Spagnoli, G. C. and Iezzi, G.. (2014) Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-beta. International journal of cancer, Vol. 134, H. 11. pp. 2583-2594.

Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Emmert, M. Y. and Hoerstrup, S. P. and Ireland, H. and Passweg, J. and Tyndall, A.. (2014) The Survey on Cellular and Engineered Tissue Therapies in Europe in 2011. Tissue engineering. Part A, Vol. 20, H. 3-4. pp. 842-853.

2012

Mumme, M. and Scotti, C. and Papadimitropoulos, A. and Todorov, A. and Hoffmann, W. and Bocelli-Tyndall, C. and Jakob, M. and Wendt, D. and Martin, I. and Barbero, A.. (2012) Interleukin-1beta modulates endochondral ossification by human adult bone marrow stromal cells. European cells & materials, Vol. 24. pp. 224-236.

Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Passweg, J. and Saris, D. and Tyndall, A.. (2012) The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue engineering. Part A, Vol. 18, H. 21-22. pp. 2268-2279.

2011

Martin, I. and Baldomero, H. and Bocelli-Tyndall, C. and Slaper-Cortenbach, I. and Passweg, J. and Tyndall, A.. (2011) The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue engineering. Part A, Vol. 17, H. 17-18. pp. 2221-2230.

2009

Daikeler, T. and Hügle, T. and Farge, D. and Andolina, M. and Gualandi, F. and Baldomero, H. and Bocelli-Tyndall, C. and Brune, M. and Dalle, J. H. and Urban, C. and Ehninger, G. and Gibson, B. and Linder, B. and Lioure, B. and Marmont, A. and Matthes-Martin, S. and Nachbaur, D. and Schuetz, P. and Tyndall, A. and van Laar, J. M. and Veys, P. and Saccardi, R. and Gratwohl, A.. (2009) Allogeneic hematopoietic SCT for patients with autoimmune diseases. Biology of blood and marrow transplantation : official journal of the American Society for Blood and Marrow Transplantation, Vol. 44. pp. 27-33.

Bocelli-Tyndall, C. and Bracci, L. and Schaeren, S. and Feder-Mengus, C. and Barbero, A. and Tyndall, A. and Spagnoli, G. C.. (2009) Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Annals of the rheumatic diseases : ARD, Vol. 68. pp. 1352-1359.

2008

Larghero, J. and Farge, D. and Braccini, A. and Lecourt, S. and Scherberich, A. and Foïs, E. and Verrecchia, F. and Daikeler, T. and Gluckman, E. and Tyndall, A. and Bocelli-Tyndall, C.. (2008) Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Annals of the rheumatic diseases : ARD, Vol. 67, H. 4. pp. 443-449.

2007

Bocelli-Tyndall, C. and Bracci, L. and Spagnoli, G. and Braccini, A. and Bouchenaki, M. and Ceredig, R. and Pistoia, V. and Martin, I. and Tyndall, A.. (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology, 46 (3). pp. 403-408.